Add-on Acquisition • Life Science

Serentis Acquires Surface Therapeutics

On September 24, 2007, Serentis acquired life science company Surface Therapeutics

Acquisition Context

This is Serentis’ 1st transaction in the Life Science sector.
This is Serentis’ 1st transaction in the United Kingdom.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 24, 2007
Target	Surface Therapeutics
Sector	Life Science
Buyer(s)	Serentis
Deal Type	Add-on Acquisition

Target Company

Surface Therapeutics

Abingdon, United Kingdom

Surface Therapeutics, Ltd. develops drugs and diagnostics for asthma, childhood eczema, and other allergic diseases.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Buyer Overview 1

Buyer

Serentis

Cambridge, United Kingdom

Category	Company
Founded	2006
Sector	Life Science

DESCRIPTION

Serentis Limited engages in the development of medical products and drugs.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
Country: United Kingdom	1 of 1
Year: 2007	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - United Kingdom M&A - 2007 M&A